Latest revenue
$5.8M
as of 2026-03-31
Latest net income
$-309.0K
as of 2026-03-31
Net margin
-5.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $287.8M
- Enterprise value
- $287.8M
- P/E (trailing)
- 209.2×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $14.71
- 52-wk low
- $3.41
- Beta
- —
- Shares out
- 52.2M
5-year trend
dashed bar = fiscal Q4 derived from 10-K annual − Q1 − Q2 − Q3 (SEC requires only three 10-Qs per year).
What this company does
CN Healthy Food Tech Group develops, manufactures, and sells premium health foods in China, including peptide-selenium powders, herbal beverages, and grain-based nutritional products rooted in traditional Chinese medicine. Revenue comes from selling these health foods through a hybrid model combining online e-commerce, distributor-run physical stores, and offline promotional events across China. The company began trading on Nasdaq under ticker UCFI on October 1, 2025 following a SPAC merger with Iron Horse Acquisition Corp., but Nasdaq immediately halted the stock pending China Securities Regulatory Commission review of the listing.
Generated from UCFI's filing dated 2026-03-31
Key risks
- Trading halted: Nasdaq suspended UCFI/UCFIW shares on/after October 1, 2025 listing because CSRC had not completed review of U.S. listing.
- China holding-company structure: operations are PRC subsidiaries subject to CSRC, antitrust, cybersecurity and data-privacy rules that could render shares worthless.
- Post-SPAC integration risk: business only closed September 30, 2025 via Iron Horse merger, leaving limited combined operating history and unproven public-company controls.
Generated from UCFI's filing dated 2026-03-31
Profitability
Return on equity
-51.1%
545.5%Return on assets
1.9%
526.5%Leverage
Debt / equity
-28.06×
4.3%Debt / assets
103.7%
0.2%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $5.8M | +20.8% | $-309.0K | -468.9% | -5.3% |
Q3 2025 2025-09-30 | $7.9M | +84.2% | $3.3M | +618.5% | 42.3% |
Q2 2025 2025-06-30 | — | — | $19.8K | -95.9% | — |
Q1 2025 2025-03-31 | $4.8M | — | $83.8K | -82.3% | 1.7% |
Q4 2024 2024-12-31 | — | — | $-45.1K | — | — |
Q3 2024 2024-09-30 | $4.3M | — | $465.5K | +439.5% | 10.8% |
Q2 2024 2024-06-30 | — | — | $481.9K | +899.0% | — |
Q1 2024 2024-03-31 | — | — | $473.4K | — | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Food and Kindred Products · SIC 2000
Your notes
Keep private notes on UCFI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns UCFI
Institutional value
$26.9K
Total shares held
4.9K
Distinct holders
3
-9 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 3.9K | $21.7K | +0 (+0.0%) | No change |
| 2 | LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 864 | $4.8K | +0 (+0.0%) | No change |
| 3 | Russell Investments Group, Ltd. | 90 | $496 | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
- 1
Trading was halted October 1 pending CSRC review—what specific filings remain outstanding, and when do you expect resumption?
- 2
With no disclosed revenue or net income figures, can you quantify 2024 sales by SKU and gross margin trajectory?
- 3
What contingency exists if CSRC denies overseas listing approval—will shareholders face delisting or forced redemption at the SPAC trust value?
Refreshed when UCFI files a new report · last from 2026-03-31